Several groups eloquently demonstrated that selective pressure from chemotherapy expands preexisting CH clones, leading to sMN development in non-Hodgkin lymphoma cohorts (5, 7, 25). This evidence concerns the gene C4B and non-Hodgkin lymphoma.